| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |